Delta Gets Blowback for Using AI to Set Airfares
For months, the Atlanta-based carrier has been working with Fetcherr, a startup that aims to transform airline pricing the way that algorithmic trading upended financial markets.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
3 Side Gigs That Could Struggle in a High-Tariff Economy
The world is bracing for a changing economy as many of President Trump's new tariffs go into effect. Not only will these added costs on imports hurt Americans' wallets, they could make earning money in the gig economy harder, too. Consider This: Read Next: Trump announced on Wednesday, July 16 that he would send a letter implementing tariffs on goods from 150 smaller countries. Tariffs with larger trade partners, including Mexico, the European Union and Canada would also go into effect on August 1. Tariffs already in effect include a 25% tariff on vehicle import and auto parts, a 30% tariff on many Chinese imports, and up to 50% on steel and aluminum, according to NewsNation. These tariffs will affect prices on consumer goods, which, in turn, could hurt small businesses and gig workers. GOBankingRates spoke with Keith Spencer, career expert at Resume Now, to find out which gig workers could be hit hardest by tariffs in 2025. Rideshare and Delivery Drivers Drivers for companies like Uber and Lyft could feel the sting of tariffs on oil imports, motor vehicles and car parts, which would increase their business costs. 'Fuel, tires and parts, many of which are imported, become more expensive,' Spencer said. At the same time, demand might decrease. Faced with rising costs, people might forgo little luxuries like ordering DoorDash or having their groceries delivered via InstaCart. 'In a high-tariff economy, side gigs that rely heavily on consumer convenience tend to struggle first,' Spencer said. 'When prices rise, people naturally start cutting back on discretionary spending. That often impacts gig workers who depend on steady, high-volume demand.' Learn More: Task-Based Gigs and Home Help People who have been making money doing random tasks around the home through services like TaskRabbit may struggle to find customers. People who assemble furniture, mount TVs or perform small contracting and handyman tasks around the home will likely feel the impact of tariffs. People may choose to complete these tasks on their own rather than hiring someone. Plus, Spencer said, 'If the price of imported goods like furniture or electronics increases, people may delay or avoid those purchases. That naturally reduces demand for anyone offering services to set them up. Even when demand is steady, the cost of tools and materials often rises, which means gig workers are spending more out of pocket just to do their jobs.' Online Resellers If you've been earning money through eBay, Facebook Marketplace or affiliate sales, you may want to brace yourself for reduced sales and shrinking profit margins. 'If your side hustle involves sourcing products from overseas, such as electronics, clothing or beauty items, you may see your margins shrink,' Spencer said. 'Tariffs raise the base cost of goods, and consumers may push back on higher prices. That combination makes it harder for solo sellers to compete or stay profitable.' What To Do Instead While some gig workers may struggle, it doesn't mean the gig economy is dead. 'Not all side gigs are equally vulnerable,' Spencer said. Pointing to recent data from Resume Now, he noted that administrative support roles saw a 10% pay increase in the first quarter of 2025. Remote healthcare support has seen 70% year-over-year growth, based on further Resume Now data. 'Workers who want to future-proof their income in a high-tariff or high-cost economy might consider transitioning into roles that are both essential and automation-resistant,' Spencer advised. 'The side gigs most likely to succeed in a high-tariff economy are those that meet essential needs, help others cut costs, or can be performed remotely.' More From GOBankingRates Mark Cuban Warns of 'Red Rural Recession' -- 4 States That Could Get Hit Hard 7 Luxury SUVs That Will Become Affordable in 2025 6 Hybrid Vehicles To Stay Away From in Retirement This article originally appeared on 3 Side Gigs That Could Struggle in a High-Tariff Economy Sign in to access your portfolio
Yahoo
26 minutes ago
- Yahoo
Nektar Therapeutics (NASDAQ:NKTR) is a favorite amongst institutional investors who own 53%
Key Insights Significantly high institutional ownership implies Nektar Therapeutics' stock price is sensitive to their trading actions A total of 17 investors have a majority stake in the company with 50% ownership Insiders have been selling lately We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. Every investor in Nektar Therapeutics (NASDAQ:NKTR) should be aware of the most powerful shareholder groups. With 53% stake, institutions possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn). Because institutional owners have a huge pool of resources and liquidity, their investing decisions tend to carry a great deal of weight, especially with individual investors. Hence, having a considerable amount of institutional money invested in a company is often regarded as a desirable trait. Let's delve deeper into each type of owner of Nektar Therapeutics, beginning with the chart below. Check out our latest analysis for Nektar Therapeutics What Does The Institutional Ownership Tell Us About Nektar Therapeutics? Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices. Nektar Therapeutics already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Nektar Therapeutics' historic earnings and revenue below, but keep in mind there's always more to the story. Since institutional investors own more than half the issued stock, the board will likely have to pay attention to their preferences. It would appear that 13% of Nektar Therapeutics shares are controlled by hedge funds. That worth noting, since hedge funds are often quite active investors, who may try to influence management. Many want to see value creation (and a higher share price) in the short term or medium term. Our data shows that Charles Schwab Investment Management, Inc. is the largest shareholder with 8.3% of shares outstanding. BVF Partners L.P. is the second largest shareholder owning 7.4% of common stock, and Millennium Management LLC holds about 5.4% of the company stock. A closer look at our ownership figures suggests that the top 17 shareholders have a combined ownership of 50% implying that no single shareholder has a majority. While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future. Insider Ownership Of Nektar Therapeutics The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it. I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions. Our data suggests that insiders own under 1% of Nektar Therapeutics in their own names. It has a market capitalization of just US$397m, and the board has only US$4.0m worth of shares in their own names. Many investors in smaller companies prefer to see the board more heavily invested. You can click here to see if those insiders have been buying or selling. General Public Ownership With a 33% ownership, the general public, mostly comprising of individual investors, have some degree of sway over Nektar Therapeutics. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies. Next Steps: While it is well worth considering the different groups that own a company, there are other factors that are even more important. Take risks for example - Nektar Therapeutics has 4 warning signs (and 3 which can't be ignored) we think you should know about. But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
26 minutes ago
- Yahoo
Highwood Asset Management (CVE:HAM) shareholders have endured a 67% loss from investing in the stock five years ago
Generally speaking long term investing is the way to go. But that doesn't mean long term investors can avoid big losses. For example, after five long years the Highwood Asset Management Ltd. (CVE:HAM) share price is a whole 67% lower. That's an unpleasant experience for long term holders. It's worthwhile assessing if the company's economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let's do just that. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS). Highwood Asset Management became profitable within the last five years. Most would consider that to be a good thing, so it's counter-intuitive to see the share price declining. Other metrics might give us a better handle on how its value is changing over time. Revenue is actually up 42% over the time period. A more detailed examination of the revenue and earnings may or may not explain why the share price languishes; there could be an opportunity. The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail). We consider it positive that insiders have made significant purchases in the last year. Even so, future earnings will be far more important to whether current shareholders make money. So it makes a lot of sense to check out what analysts think Highwood Asset Management will earn in the future (free profit forecasts). A Different Perspective Investors in Highwood Asset Management had a tough year, with a total loss of 1.3%, against a market gain of about 22%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. However, the loss over the last year isn't as bad as the 11% per annum loss investors have suffered over the last half decade. We'd need to see some sustained improvements in the key metrics before we could muster much enthusiasm. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Take risks, for example - Highwood Asset Management has 4 warning signs (and 1 which can't be ignored) we think you should know about. If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: most of them are flying under the radar). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Canadian exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
